Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Complete Genomics Inc.
Headquarters: Mountain View, CA, United States of America
Website: N/A
Year Founded: 2005
Status: Acquired
BioCentury | Jul 8, 2022
Finance
2Q22 Wrap: it could be worse
Bleeding continued in biopharma in second quarter, with median market caps down in all tiers
BioCentury | Jun 26, 2020
Politics, Policy & Law
Illumina, BGI litigation not yet at risk of getting drawn into U.S.-China dispute
Developments to watch for include any emerging lawsuits in Chinese courts or unusual rulings
BioCentury | Jun 17, 2020
Product Development
June 16 Quick Takes: Takeda out-licenses neurology pipeline to Neurocrine; plus Illumina challenge blocks BGI, FDA approves a pair of firsts and more
BioCentury | Feb 28, 2020
Product Development
Feb. 27 Quick Takes: FDA approves Biohaven’s migraine therapy, plus Acacia, Zogenix, Ultragenyx-Kyowa, GSK, Illumina-BGI
BioCentury | Jul 24, 2019
Company News
July 24 Management tracks: GSK, Goldman Sachs, Ziopharm and Alkahest
BioCentury | Oct 19, 2018
Politics, Policy & Law
CFIUS waiting game
How CFIUS expansion could adversely affect U.S. biotechs raising foreign capital
BioCentury | Oct 11, 2018
Strategy
Border security for China’s genomes
Balancing protection and translation for China’s genomic data troves
BioCentury | Jun 28, 2018
Politics & Policy
Broader CFIUS jurisdiction may have implications for biotech
Items per page:
1 - 10 of 107